Lemborexant

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Healthy Volunteer

Conditions

Healthy Volunteer

Trial Timeline

Oct 26, 2020 → Jan 13, 2021

NCT ID

NCT04555733

About Lemborexant

Lemborexant is a phase 1 stage product being developed by Eisai for Healthy Volunteer. The current trial status is completed. This product is registered under clinical trial identifier NCT04555733. Target conditions include Healthy Volunteer.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Volunteer were approved

Approved (20) Terminated (1) Active (0)

✅mRNA-1273.712ModernaApproved

✅Cholestyramine + Colesevelam HClDaiichi SankyoApproved

✅Cholestyramine + Cholestyramine + TangDaiichi SankyoApproved

✅Olmesartan medoxomil + Irbesartan + ValsartanDaiichi SankyoApproved

✅Perampanel 6 MGEisaiApproved

✅eszopiclone, zolpidem, placeboSumitomo PharmaApproved

✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT05594589	Phase 2	Completed	Nov 30, 2022	May 24, 2024	Sleep Initiation and Maintenance Disorders
NCT04890561	Phase 1	Completed	May 17, 2021	Aug 12, 2021	Healthy Volunteers
NCT04555733	Phase 1	Completed	Oct 26, 2020	Jan 13, 2021	Healthy Volunteer
NCT04573556	Pre-clinical	Completed	Oct 17, 2020	Mar 17, 2022	Sleep Initiation and Maintenance Disorders
NCT03443063	Phase 1	Completed	Feb 7, 2018	Aug 24, 2018	Renal Impairment
NCT03440424	Phase 1	Completed	Jan 26, 2018	Apr 23, 2018	Hepatic Impairment

Competing Products

20 competing products in Healthy Volunteer

See all competitors

Product	Company	Stage	Hype Score
Use of Wearable Digital Sensors After mRNA Vaccination in Adults	Moderna	Preclinical	0
mRNA-0184	Moderna	Phase 1	0
mRNA-6231	Moderna	Phase 1	0
Letrozole	Dr. Reddy's Laboratories	Phase 1	26
Isotretinoin	Dr. Reddy's Laboratories	Phase 1	26
Fexofenadine	Dr. Reddy's Laboratories	Phase 1	26
Sertraline	Dr. Reddy's Laboratories	Phase 1	26
Nizatidine + Axid	Dr. Reddy's Laboratories	Phase 1	26
Anastrozole	Dr. Reddy's Laboratories	Phase 1	26
mRNA-1273.712	Moderna	Approved	0
Risperidone	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
Metformin + Glucophage	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
mRNA-0184	Moderna	Phase 1	0
Divalproex Sodium	Dr. Reddy's Laboratories	Phase 1	26
Sirolimus	Dr. Reddy's Laboratories	Phase 1	26
Glimepiride	Dr. Reddy's Laboratories	Phase 1	26
Ziprasidone Hydrochloride	Dr. Reddy's Laboratories	Phase 1	26
Naproxen sodium	Dr. Reddy's Laboratories	Phase 1	26